Relevance of RIBA‐3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors

HCV antibody screening of 624,910 blood donations resulted in 3,832 samples being referred for confirmation. All were tested by RIBA‐3 with 2,710 negative, 945 indeterminate and 177 positive results. HCV RNA was detected by PCR in an average of 69.5% of RIBA‐3 positives (4 bands 84.1%; 3 bands 74.1%; 2 bands 34.1%) and only 0.53% of RIBA‐3 indeterminates. Eighty‐four percent of samples with a total RIBA‐3 band intensity score (maximum 16) of ≥8 were PCR positive compared with only 22% of those with a score of <8. Total mean band intensities for HCV genotype 1 samples (n = 65) were 13.2, genotype 2 (n = 17) 11.4 and genotype 3 (n = 65) 11.2 with type 1 samples showing greater reactivity with c100 and c33 antibodies. No PCR positive type 1 samples were found with RIBA‐3 total band scores less than 8, no PCR positive type 2 samples less than 6, whilst PCR positive type 3 samples were found with scores as low as 2. NS5 indeterminates were the most common (40.2%) single band pattern but yielded no PCR positive samples, followed by c33 (23.3%) with one PCR positive and c100 (20.2%) with one PCR positive whilst c22 indeterminates were least common (16.3%) but included three PCR positive donors. All five RIBA‐3 indeterminate PCR positive donors were type 3. © 1996 Wiley‐Liss, Inc.

[1]  H. Vrielink,et al.  Reliability of the third‐generation recombinant immunoblot assay for hepatitis C virus , 1995, Transfusion.

[2]  H. Vrielink,et al.  Sensitivity and Specificity of Three Third‐Generation Anti‐Hepatitis C Virus ELISAs , 1995, Vox sanguinis.

[3]  P. Simmonds,et al.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. , 1995, The Journal of general virology.

[4]  A. Couroucé,et al.  Anti‐hepatitis C virus (anti‐HCV) seroconversion in patients undergoing hemodialysis: comparison of second‐ and third‐generation anti‐HCV assays , 1994, Transfusion.

[5]  M. Jadoul,et al.  Significance of NS3 and NS5 antigens in screening for HCV antibody , 1994, The Lancet.

[6]  A. Keller,et al.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey , 1994, Journal of clinical microbiology.

[7]  P. Simmonds,et al.  Testing of blood donations for hepatitis C virus , 1994, The Lancet.

[8]  H. Reesink,et al.  Should the c100 Antigen Be Removed from HCV Antibody Assays? , 1994, Vox sanguinis.

[9]  P. Simmonds,et al.  Confirmation of hepatitis C virus antibody in blood donors , 1993, Journal of medical virology.

[10]  P. Simmonds,et al.  Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities , 1993, Transfusion.

[11]  E. Holmes,et al.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. , 1992, The Journal of general virology.